BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34838524)

  • 1. Incidental Findings on Low-Dose CT Scan Lung Cancer Screenings and Deaths From Respiratory Diseases.
    Pinsky PF; Lynch DA; Gierada DS
    Chest; 2022 Apr; 161(4):1092-1100. PubMed ID: 34838524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant Incidental Findings in the National Lung Screening Trial.
    Gareen IF; Gutman R; Sicks J; Tailor TD; Hoffman RM; Trivedi AN; Flores E; Underwood E; Cochancela J; Chiles C
    JAMA Intern Med; 2023 Jul; 183(7):677-684. PubMed ID: 37155190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COPD phenotypes in a lung cancer screening population.
    Balkan A; Bulut Y; Fuhrman CR; Fisher SN; Wilson DO; Weissfeld JL; Sciurba FC
    Clin Respir J; 2016 Jan; 10(1):48-53. PubMed ID: 24989058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population.
    Goffin JR; Pond GR; Puksa S; Tremblay A; Johnston M; Goss G; Nicholas G; Martel S; Bhatia R; Liu G; Schmidt H; Atkar-Khattra S; McWilliams A; Tsao MS; Tammemagi MC; Lam S
    BMC Pulm Med; 2020 Nov; 20(1):300. PubMed ID: 33198781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Emphysema on Low-Dose CT Imaging of the Chest and Risk of Lung Cancer and Airflow Obstruction: An Analysis of the National Lung Screening Trial.
    Labaki WW; Xia M; Murray S; Hatt CR; Al-Abcha A; Ferrera MC; Meldrum CA; Keith LA; Galbán CJ; Arenberg DA; Curtis JL; Martinez FJ; Kazerooni EA; Han MK
    Chest; 2021 May; 159(5):1812-1820. PubMed ID: 33326807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment.
    Pinsky PF; Gierada DS; Black W; Munden R; Nath H; Aberle D; Kazerooni E
    Ann Intern Med; 2015 Apr; 162(7):485-91. PubMed ID: 25664444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term cancer risk associated with lung nodules observed on low-dose screening CT scans.
    Pinsky P; Gierada DS
    Lung Cancer; 2020 Jan; 139():179-184. PubMed ID: 31812129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The added value of hybrid ventilation/perfusion SPECT/CT in patients with stable COPD or apparently healthy smokers. Cancer-suspected CT findings in the lungs are common when hybrid imaging is used.
    Jögi J; Markstad H; Tufvesson E; Bjermer L; Bajc M
    Int J Chron Obstruct Pulmon Dis; 2015; 10():25-30. PubMed ID: 25565797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-Level Trajectories and Outcomes After Low-Dose CT Screening in the National Lung Screening Trial.
    Iaccarino JM; Silvestri GA; Wiener RS
    Chest; 2019 Nov; 156(5):965-971. PubMed ID: 31283920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary emphysema and coronary artery calcifications at baseline LDCT and long-term mortality in smokers and former smokers of the ITALUNG screening trial.
    Mascalchi M; Romei C; Marzi C; Diciotti S; Picozzi G; Pistelli F; Zappa M; Paci E; Carozzi F; Gorini G; Falaschi F; Deliperi AL; Camiciottoli G; Carrozzi L; Puliti D
    Eur Radiol; 2023 May; 33(5):3115-3123. PubMed ID: 36854875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-off low-dose CT for lung cancer screening in China: a multicentre, population-based, prospective cohort study.
    Li N; Tan F; Chen W; Dai M; Wang F; Shen S; Tang W; Li J; Yu Y; Cao W; Xu Y; Qin C; Zhao L; Zhu M; Guo L; Wu Z; Yang Z; Zheng Y; Chen H; Liu Y; Wei D; Dong D; Cao J; Zhang S; Yan S; Wang N; Du L; Shen H; Wu N; He J;
    Lancet Respir Med; 2022 Apr; 10(4):378-391. PubMed ID: 35276087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study.
    Chang GC; Chiu CH; Yu CJ; Chang YC; Chang YH; Hsu KH; Wu YC; Chen CY; Hsu HH; Wu MT; Yang CT; Chong IW; Lin YC; Hsia TC; Lin MC; Su WC; Lin CB; Lee KY; Wei YF; Lan GY; Chan WP; Wang KL; Wu MH; Tsai HH; Chian CF; Lai RS; Shih JY; Wang CL; Hsu JS; Chen KC; Chen CK; Hsia JY; Peng CK; Tang EK; Hsu CL; Chou TY; Shen WC; Tsai YH; Tsai CM; Chen YM; Lee YC; Chen HY; Yu SL; Chen CJ; Wan YL; Hsiung CA; Yang PC;
    Lancet Respir Med; 2024 Feb; 12(2):141-152. PubMed ID: 38042167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Jonas DE; Reuland DS; Reddy SM; Nagle M; Clark SD; Weber RP; Enyioha C; Malo TL; Brenner AT; Armstrong C; Coker-Schwimmer M; Middleton JC; Voisin C; Harris RP
    JAMA; 2021 Mar; 325(10):971-987. PubMed ID: 33687468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of radiographic emphysema in assessing lung cancer risk.
    Yong PC; Sigel K; de-Torres JP; Mhango G; Kale M; Kong CY; Zulueta JJ; Wilson D; Brown SW; Slatore C; Wisnivesky J
    Thorax; 2019 Sep; 74(9):858-864. PubMed ID: 30723183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial.
    Becker N; Motsch E; Trotter A; Heussel CP; Dienemann H; Schnabel PA; Kauczor HU; Maldonado SG; Miller AB; Kaaks R; Delorme S
    Int J Cancer; 2020 Mar; 146(6):1503-1513. PubMed ID: 31162856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of cancer characteristics and patient outcome with time to lung cancer diagnosis after an abnormal screening CT.
    Sonavane SK; Pinsky P; Watts J; Gierada DS; Munden R; Singh SP; Nath H
    Eur Radiol; 2017 Dec; 27(12):5113-5118. PubMed ID: 28616728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overdiagnosis in low-dose computed tomography screening for lung cancer.
    Patz EF; Pinsky P; Gatsonis C; Sicks JD; Kramer BS; Tammemägi MC; Chiles C; Black WC; Aberle DR;
    JAMA Intern Med; 2014 Feb; 174(2):269-74. PubMed ID: 24322569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical Care Costs Were Similar Across the Low-dose Computed Tomography and Chest X-Ray Arms of the National Lung Screening Trial Despite Different Rates of Significant Incidental Findings.
    Gareen IF; Black WC; Tosteson TD; Wang Q; Sicks JD; Tosteson ANA
    Med Care; 2018 May; 56(5):403-409. PubMed ID: 29613874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving selection criteria for lung cancer screening. The potential role of emphysema.
    Sanchez-Salcedo P; Wilson DO; de-Torres JP; Weissfeld JL; Berto J; Campo A; Alcaide AB; Pueyo J; Bastarrika G; Seijo LM; Pajares MJ; Pio R; Montuenga LM; Zulueta JJ
    Am J Respir Crit Care Med; 2015 Apr; 191(8):924-31. PubMed ID: 25668622
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.